ACRP30, a new hormone controlling fat and glucose metabolism

Author： Tsao T.-S.   Lodish H.F.   Fruebis J.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.440, Iss.2, 2002-04, pp. : 213-221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

gAcrp30 increases free fatty acid (FFA) oxidation and promotes bodyweight loss in mice

By  

Inpharma, Vol. 1, Iss. 1284, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Dual Roles of Adiponectin / Acrp30 In Vivo as an Anti-Diabetic and Anti- Atherogenic Adipokine

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 3, Iss. 4, 2003-12 ,pp. : 243-253

Bentham Science Publishers

Access to resources Recommend Favorite

Glucose Metabolism and Antidepressant Medication

By  

Current Pharmaceutical Design, Vol. 18, Iss. 36, 2012-12 ,pp. : 5900-5919

Bentham Science Publishers

Access to resources Recommend Favorite

Glucose metabolism disorders with atypical antipsychotics

By  

Inpharma, Vol. 1, Iss. 1310, 2001-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Octreotide detrimental to glucose metabolism in acromegaly

By  

Inpharma, Vol. 1, Iss. 1346, 2002-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite